Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 15, 2026, 12:27 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 73–96 of 358 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: total hip arthroplasty Clear all

Conditions: Prosthetic Joint Infection
Interventions: TNP-2092; Drug
Lead sponsor: TenNor Therapeutics Limited; Industry
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Metabolic Profiling Muscle
Interventions: CT, Ultrasound; Procedure · Device
Lead sponsor: Duke University; Other
Eligibility: 18 Years and older
Enrollment: 18 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2025
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Joint Replacement, Arthropathy
Interventions: Patient-Specific Orthopedic Implant; Device
Lead sponsor: Restor3D; Industry
Eligibility: 18 Years and older
Enrollment: 2,250 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2032
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Arthroplasty, Replacement, Hip
Interventions: Pelvic Alignment Level (PAL) Instrument, No Pelvic Alignment Level (PAL) Instrument; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2012
U.S. locations: 1
States / cities: Louisville, Kentucky

Conditions: Osteoarthritis
Interventions: Peri-articular injection of marcaine/epinephrine, Peri-articular injection of marcaine alone; Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 19 Years to 80 Years
Enrollment: 33 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2012
U.S. locations: 1
States / cities: Chicago, Illinois

Conditions: Total Hip Arthroplasty, Primary Total Hip Arthroplasty, Hypotension, Database
Interventions: Chart Review; Other
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years and older
Enrollment: 11,292 participants
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Osteoarthritis, Acetaminophen, Arthroplasty, Hip Replacement
Interventions: Intravenous acetaminophen, Oral acetaminophen; Drug
Lead sponsor: Duke University; Other
Eligibility: 56 Years to 85 Years
Enrollment: 81 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2018
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Blood Loss, Blood Transfusion
Interventions: Tranexamic Acid; Drug
Lead sponsor: Hospital for Special Surgery, New York; Other
Eligibility: 18 Years to 80 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: New York, New York

Conditions: Infections Joint Prosthetic, Overweight or Obesity, MSSA Colonization, MRSA, Chronic Kidney Diseases, Diabetes, Autoimmune Diseases, Inflammatory Disease, Tobacco Use
Interventions: Cephalexin, Doxycycline, Cefadroxil; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years to 99 Years
Enrollment: 4,618 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2028
U.S. locations: 2
States / cities: Iowa City, Iowa • Rochester, Minnesota

Conditions: Osteoarthritis
Interventions: Not listed
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 20 Years to 75 Years
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2023
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Post Operative Pain, Total Hip Arthroplasty
Interventions: Methadone; Drug
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 18 Years to 75 Years
Enrollment: 162 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Osteo Arthritis Knee
Interventions: Melatonin 5 mg, Placebo; Drug · Other
Lead sponsor: NYU Langone Health; Other
Eligibility: 18 Years to 95 Years
Enrollment: 294 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: Total Hip Arthroplasty
Interventions: PNB Bupivacaine, PAI Ropivacaine, PAI liposomal bupivacaine, Epinephrine, Ketorolac; Drug
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 165 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2016
U.S. locations: 1
States / cities: Rochester, Minnesota

Conditions: Pain, Postoperative, Arthroplasty Complications
Interventions: Ketamine; Drug
Lead sponsor: Dartmouth-Hitchcock Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 200 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: Lebanon, New Hampshire

Conditions: Primary Total Hip Arthroplasty
Interventions: Primary Total Hip Replacement with Trinity cup and TriFit TS stem via posterolateral surgical approach., Primary Total Hip Replacement with Trinity cup and MetaFix stem via direct anterior surgical approach; Device
Lead sponsor: Corin; Industry
Eligibility: 21 Years to 85 Years
Enrollment: 55 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Revision Total Knee Arthroplasty, Revision Total Hip Arthroplasty, Acute Blood Loss Anemia
Interventions: Revision Total Knee Arthroplasty (TKA), Revision Total Hip Arthroplasty (THA); Procedure
Lead sponsor: Rush University Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 175 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016 – 2019
U.S. locations: 3
States / cities: Chicago, Illinois • Rochester, Minnesota • New York, New York

Conditions: Prevention, Venous Thromboembolism
Interventions: Rivaroxaban (BAY59-7939), Enoxaparin; Drug
Lead sponsor: Bayer; Industry
Eligibility: 18 Years and older
Enrollment: 2,457 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2007
U.S. locations: 5
States / cities: Birmingham, Alabama • Denver, Colorado • Bay Pines, Florida + 2 more

Conditions: Hip Osteoarthritis, Avascular Necrosis, Rheumatoid Arthritis, Post-traumatic Osteoarthritis, Femoral Neck Fractures, Trochanteric Fractures, Surgery
Interventions: Insignia uncemented Hip Stem; Device
Lead sponsor: Stryker Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 313 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2022 – 2034
U.S. locations: 11
States / cities: Phoenix, Arizona • San Francisco, California • Chicago, Illinois + 8 more

Conditions: Hip Osteoarthritis, Rheumatoid Arthritis, Joint Diseases, Avascular Necrosis, Dislocation, Hip, Femoral Neck Fractures, Trochanteric Fractures, Revision Surgeries
Interventions: G7 Dual Mobility with Vivacit-E bearing, G7 Dual Mobility Longevity bearing; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 80 Years
Enrollment: 358 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2037
U.S. locations: 6
States / cities: Little Rock, Arkansas • Jersey City, New Jersey • New York, New York + 3 more

Conditions: Total Knee Arthroplasty; Total Hip Arthroplasty
Interventions: Health Partner, Standard Care; Behavioral
Lead sponsor: DePuy Orthopaedics; Industry
Eligibility: 18 Years and older
Enrollment: 79 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 3
States / cities: Newberg, Oregon • Spokane, Washington

Conditions: Advanced Hip Disease
Interventions: Durom Hip Resurfacing System; Device
Lead sponsor: Zimmer Biomet; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 40 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2011
U.S. locations: 5
States / cities: Denver, Colorado • De Witt, New York • Tulsa, Oklahoma + 2 more

Conditions: Osteoarthritis, Hip
Interventions: KINCISE, Traditional Handheld Mallet; Device
Lead sponsor: University of Cincinnati; Other
Eligibility: 21 Years and older
Enrollment: 50 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 1
States / cities: Cincinnati, Ohio

Conditions: Degenerative Osteoarthritis
Interventions: Benzoyl peroxide gel; Drug
Lead sponsor: Colorado Joint Replacement; Other
Eligibility: 18 Years to 85 Years
Enrollment: 496 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2019 – 2024
U.S. locations: 1
States / cities: Denver, Colorado

Conditions: Osteoarthritis of Hip, Regional Anesthesia, Other Acute Postoperative Pain, Total Hip Arthroplasty, Peripheral Nerve Block, Lumbar Plexus Nerve Block, Parasacaral (Sciatic) Nerve Block
Interventions: Continuous Lumbar Plexus Block, Parasacral Nerve Block, Ropivacine 0.2%, Bupivacaine 0.0625%; Procedure · Drug
Lead sponsor: Rita Merman; Other
Eligibility: 18 Years to 75 Years
Enrollment: 10 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014
U.S. locations: 1
States / cities: Pittsburgh, Pennsylvania

Search by objective public record fields.

Tissue Distribution, Pharmacokinetics, Safety, and Tolerability After a Single Dose of TNP-2092 in Participants Undergoing Primary Total Hip or Knee Arthroplasty

HIP: Hip Imaging Protocol

The restor3d Outcomes Registry

Pelvic Alignment Level (PAL) Instrument Evaluation

Study Comparing Peri-articular Injection of Bupivacaine With and Without Epinephrine

Outcomes After Hypotensive Neuraxial Anesthesia in Total Hip Arthroplasty

Intravenous Versus Oral Acetaminophen in Primary Total Hip Arthroplasty

Oral Versus Intravenous Tranexamic Acid

Antibiotic Prophylaxis in High-Risk Arthroplasty Patients

Outcomes of Robotic Total Hip Arthroplasty

Methadone in THA for Post-op Pain and Opioid Reduction

Melatonin Use After Primary Total Joint Arthroplasty

Total Hip Arthroplasty (THA) Lumbar Plexus Verses Periarticular

Intraoperative Ketamine for Patients Undergoing Total Joint Arthroplasty

Accuracy of OPS™ Femoral Neck Resection Study

Tranexamic Acid in Revision Total Joint Arthroplasty

Regulation of Coagulation in Orthopedic Surgery to Prevent DVT and PE, a Controlled, Double-blind, Randomized Study of BAY 59-7939 in the Extended Prevention of VTE in Patients Undergoing Elective Total Hip Replacement

Insignia™ Hip Stem Outcomes Study

G7 Dual Mobility With Vivacit-E or Longevity PMCF

Health Partner Evaluation at Providence

Durom(R) Hip Resurfacing System Multicenter Trial

KINCISE™ Surgical Automated System in Total Hip Arthroplasty (THA)

Cutibacterium Dermal Colonization: Implications for Total Hip Arthroplasty

Continuous Lumbar Plexus Block With and Without Parasacral Block in Patients Undergoing Total Hip Replacement